Skip to main content

Table 2 Baseline characteristics compared between the home-based exercise training and control groups

From: Effect of a 12-week home-based exercise training program on aerobic capacity, muscle mass, liver and spleen stiffness, and quality of life in cirrhotic patients: a randomized controlled clinical trial

Characteristics

HoBET (n = 20)

Control (n = 20)

p-value

Age (years), mean ± SD

55.6 ± 8.9

57.1 ± 6.7

0.56

Male gender, n (%)

15 (75%)

11 (55%)

0.18

Etiology of cirrhosis, n (%)

 Hepatitis B infection

11 (55%)

8 (40%)

0.34

 Hepatitis C infection

7 (35%)

11 (55%)

0.20

 Alcohol

1 (5%)

1 (5%)

1.00

 Non-alcoholic steatohepatitis

1 (5%)

0 (0%)

1.00

Severity of liver disease

 MELD, mean ± SD

7.95 ± 1.5

7.95 ± 1.3

1.00

 CTP score, median (range)

5 (5–5)

5 (5–5)

1.00

History of small EV, n (%)

2 (10%)

4 (20%)

0.66

History of previous EV bleeding, n (%)

1 (5%)

2 (10%)

1.00

BMI (kg/m2), mean ± SD

25.3 ± 2.7

25.2 ± 3.4

0.92

Waist circumference (cm), mean ± SD

91.3 ± 8.0

90 ± 7.4

0.61

%Fat, mean ± SD

24.6 ± 7.0

29.1 ± 9.1

0.09

Muscle mass (kg), mean ± SD

50.8 ± 7.6

44.4 ± 7.5

0.01

Laboratory results, mean ± SD

 Fasting blood sugar (mg/dL)

111.9 ± 25

106.1 ± 35.7

0.56

 Cholesterol (mg/dL)

174.1 ± 22.8

172.4 ± 32.2

0.85

 LDL-C (mg/dL)

101.7 ± 21.4

100.3 ± 32.8

0.88

 Hb (g/dl)

14.6 ± 1.4

13.3 ± 1.7

0.01

 Platelet count (X109/L)

169 ± 80

146 ± 45

0.27

 Albumin (g/dl)

4.4 ± 0.3

4.3 ± 0.4

0.85

 Total bilirubin (mg/dl), median (range)

0.72 (0.6–0.9)

0.63 (0.4–0.9)

0.21

 ALT (U/L), median (range)

25 (22–49)

27 (20–37)

0.53

 International normalized ratio (INR)

1.1 ± 0.08

1.1 ± 0.09

0.55

Creatinine (mg/dl)

0.9 ± 0.2

1.3 ± 2.3

0.43

6-min walk test (meters), mean ± SD

479.8 ± 61.1

470.6 ± 80

0.69

Transient elastography, mean ± SD

 Liver stiffness (kPa)

14.0 ± 9.6

16.6 ± 9.2

0.39

 CAP (dB/m)

235.3 ± 44.3

229.3 ± 47.9

0.69

 Spleen stiffness (kPa)

25.8 ± 16.2

33.7 ± 25.9

0.64

Thigh muscle mass, mean ± SD

 Thigh circumference (cm)

49.2 ± 3.4

48.3 ± 4.7

0.49

 Average feather index (cm/m2)

0.82 ± 0.16

0.86 ± 0.26

0.61

 Average compression index (cm/m2)

0.62 ± 0.12

0.67 ± 0.17

0.35

Quality of life, mean ± SD

 Abdominal symptoms domain

5.9 ± 1.0

5.3 ± 1.3

0.17

 Fatigue domain

5.1 ± 1.1

4.7 ± 1.1

0.29

 Systemic symptoms domain

5.8 ± 0.8

5.2 ± 1.2

0.045

 Activity domain

5.8 ± 0.8

5.3 ± 1.2

0.18

 Emotional function domain

5.4 ± 1.0

4.9 ± 1.3

0.15

 Worry domain

5.8 ± 1.5

5.1 ± 1.4

0.14

 Average CLDQ score

5.6 ± 0.9

5.1 ± 1.1

0.43

  1. A p-value < 0.05 indicates statistical significance
  2. ALT alanine aminotransferase, BMI body mass index, CAP controlled attenuation parameter, CLDQ chronic liver disease questionnaire, CTP Child-Turcotte-Pugh, EV esophageal varices, Hb hemoglobin, HoBET home-based exercise training, LDL-C low-density lipoprotein cholesterol, MELD model for end-stage liver disease